Subham Das

Subham Das works in medicinal chemistry and computational drug discovery, focusing on designing and synthesizing new small molecules (such as quinoline, benzodioxane, indole, and pyrazoline derivatives) as candidates for treating cancers, neurodegenerative diseases, and infections. Much of the research combines computer-based methods like molecular docking, virtual screening, and simulations with laboratory synthesis and biological testing to identify promising drug leads.

Publication output rose sharply from 2020 to a peak in 2022, then settled into a somewhat lower but still active and steady pace through 2024-2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026